|name||EGFLAM antisense RNA 1|
LncRNA CTD-2108O9.1 is lower in gastric cancer tissues and cell lines. Moreover, the transwell assay shows that the number of cells capable of passing through the matrigel is significantly reduced after CTD-2108O9.1 transfection. However, CTD-2108O9.1 overexpression does not significantly influence cell proliferation and cell cycle progression. Lastly, western blot and real-time PCR analysis suggests that CTD-2108O9.1 is positively correlated with the expression of leukemia inhibitory factor receptor (LIFR) gene at the translational level (1).
|LncRNA||tissue||cancer type||expression level||oncogene/suppress gene||pathway||binding gene/factor||associated gene/factor||proliferation||apoptosis||migration||EMT||invasion||metastasis||prognosis||tag||PMID|
Expression profile in human body map